Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
MMWR. Morbidity and Mortality Weekly Report
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update From the Advisory Committee on Immunization Practices — United States, June 2021
MMWR Morb. Mortal. Wkly. Rep. 2021 Jul 09;70(27)977-982, JW Gargano, M Wallace, SC Hadler, G Langley, JR Su, ME Oster, KR Broder, J Gee, E Weintraub, T Shimabukuro, HM Scobie, D Moulia, LE Markowitz, M Wharton, VV McNally, JR Romero, HK Talbot, GM Lee, MF Daley, SE OliverFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.